BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9873503)

  • 1. Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT).
    Roller PP; Wu L; Zhang ZY; Burke TR
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2149-50. PubMed ID: 9873503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
    Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
    J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibition of protein-tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides.
    Akamatsu M; Roller PP; Chen L; Zhang ZY; Ye B; Burke TR
    Bioorg Med Chem; 1997 Jan; 5(1):157-63. PubMed ID: 9043667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
    Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D
    Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine.
    Kole HK; Akamatsu M; Ye B; Yan X; Barford D; Roller PP; Burke TR
    Biochem Biophys Res Commun; 1995 Apr; 209(3):817-22. PubMed ID: 7537500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase.
    Lee K; Gao Y; Yao ZJ; Phan J; Wu L; Liang J; Waugh DS; Zhang ZY; Burke TR
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2577-81. PubMed ID: 12852970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates.
    Zhang ZY; Maclean D; McNamara DJ; Sawyer TK; Dixon JE
    Biochemistry; 1994 Mar; 33(8):2285-90. PubMed ID: 7509638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidic alpha-ketocarboxylic acids and sulfonamides as inhibitors of protein tyrosine phosphatases.
    Chen YT; Xie J; Seto CT
    J Org Chem; 2003 May; 68(10):4123-5. PubMed ID: 12737607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. 2. 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic.
    Gao Y; Luo J; Yao ZJ; Guo R; Zou H; Kelley J; Voigt JH; Yang D; Burke TR
    J Med Chem; 2000 Mar; 43(5):911-20. PubMed ID: 10715157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
    Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric synthesis of the (S)-1,1-dioxido-isothiazolidin-3-one phosphotyrosine mimetic via reduction of a homochiral (R)-oxido-isothiazolidin-3-one.
    Combs AP; Glass B; Galya LG; Li M
    Org Lett; 2007 Mar; 9(7):1279-82. PubMed ID: 17338536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.
    Burke TR; Kole HK; Roller PP
    Biochem Biophys Res Commun; 1994 Oct; 204(1):129-34. PubMed ID: 7524496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
    Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B
    J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design.
    Burke TR; Ye B; Yan X; Wang S; Jia Z; Chen L; Zhang ZY; Barford D
    Biochemistry; 1996 Dec; 35(50):15989-96. PubMed ID: 8973169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Protein-Protein Interactions of Tyrosine Phosphatases with Microarrayed Fragment Libraries Displayed on Phosphopeptide Substrate Scaffolds.
    Hogan M; Bahta M; Tsuji K; Nguyen TX; Cherry S; Lountos GT; Tropea JE; Zhao BM; Zhao XZ; Waugh DS; Burke TR; Ulrich RG
    ACS Comb Sci; 2019 Mar; 21(3):158-170. PubMed ID: 30629404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design and synthesis of small molecule protein-tyrosine phosphatase 1B inhibitors.
    Yao ZJ; Ye B; Wu XW; Wang S; Wu L; Zhang ZY; Burke TR
    Bioorg Med Chem; 1998 Oct; 6(10):1799-810. PubMed ID: 9839010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.
    Salmeen A; Andersen JN; Myers MP; Tonks NK; Barford D
    Mol Cell; 2000 Dec; 6(6):1401-12. PubMed ID: 11163213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-Activity relationship.
    Arabaci G; Yi T; Fu H; Porter ME; Beebe KD; Pei D
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3047-50. PubMed ID: 12372498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.